SOPHiA GENETICS S.A. logo SOPH - SOPHiA GENETICS S.A.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 6
HOLD 1
SELL 0
STRONG
SELL
0
| PRICE TARGET: $7.50 DETAILS
HIGH: $8.00
LOW: $7.00
MEDIAN: $7.50
CONSENSUS: $7.50
UPSIDE: 53.69%
Metric 2025 2024 2023 2022 2021 2020 2019
Revenue
Revenue 77.3 65.2 62.4 47.6 40.5 28.4 25.4
Cost of Revenue 29.5 21.2 19.5 16.3 15.2 10.7 7.5
Gross Profit 47.8 43.9 42.9 31.3 25.2 17.7 17.8
Operating Expenses
R&D Expenses 33.6 34.4 37.0 35.4 26.6 18.6 15.0
SG&A Expenses 85.2 76.3 81.7 84.1 70.2 36.4 35.1
Other Expenses 0 (0.2) (1.0) (0.4) (0.1) 0.1 0.0
Operating Expenses 118.7 110.5 117.7 119.1 96.7 55.1 50.1
Operating Income
Operating Income (70.9) (66.6) (74.8) (87.8) (71.5) (37.4) (32.3)
Interest Expense 4.6 1.9 0.6 0.6 0.7 0.8 1.0
Interest Income 1.9 3.4 4.5 1.3 0.0 0.1 0.1
Profitability
EBITDA (61.4) (50.8) (69.6) (81.4) (69.2) (38.0) (30.7)
EBIT (70.9) (59.4) (77.9) (86.9) (72.8) (40.4) (32.7)
Income Before Tax (78.5) (61.3) (78.5) (87.6) (73.5) (41.2) (33.6)
Income Tax Expense 0.5 1.2 0.5 (0.1) 0.2 (1.9) 0.2
Net Income (79.0) (62.5) (79.0) (87.4) (73.7) (39.3) (33.8)
Per Share Data
EPS (Basic) -1.17 -0.95 -1.22 -1.36 -1.33 -0.82 -0.53
EPS (Diluted) -1.17 -0.95 -1.22 -1.36 -1.33 -0.82 -0.53
Shares Outstanding 67.5 65.8 64.8 64.1 55.3 48.0 63.9
Metric 2025 2024 2023 2022 2021 2020 2019 2018
Current Assets
Cash & Cash Equivalents 70.3 80.2 123.3 161.3 193.0 74.6 18.1 53.9
Short-Term Investments 0 0 0 17.3 72.4 22.7 0.4 0.4
Net Receivables 18.5 8.7 15.2 8.1 7.1 7.9 9.7 5.1
Inventory 6.4 5.9 6.5 5.2 5.7 3.4 3.6 2.9
Other Current Assets 0.8 0.8 0.3 0.7 0.8 0.0 0.3 0.1
Total Current Assets 99.1 99.4 148.0 196.3 282.9 109.7 33.8 62.7
Non-Current Assets
Property, Plant & Equipment 18.0 19.4 23.1 21.4 16.0 5.5 6.4 4.5
Goodwill 9.6 8.3 9.0 8.2 8.3 8.6 7.8 7.7
Intangible Assets 26.3 20.7 18.2 11.8 7.4 4.7 2.4 0.8
Long-Term Investments 2.0 0 0 0 0 0.8 0.4 0.3
Other Non-Current Assets 6.2 5.8 6.1 4.3 3.7 0.7 0.8 0.6
Total Non-Current Assets 64.4 55.9 58.1 47.6 37.3 22.4 17.9 13.9
Total Assets 163.5 155.3 206.2 243.8 320.2 132.1 51.7 76.6
Current Liabilities
Account Payables 5.3 1.9 2.3 2.2 2.3 1.3 1.7 0.9
Short-Term Debt 2.7 0 0 0 0 2.9 2.2 1.9
Deferred Revenue 16.7 5.7 9.5 3.4 4.1 2.6 2.1 1.9
Other Current Liabilities 5.3 11.2 13.6 10.3 9.2 5.2 5.7 2.4
Total Current Liabilities 50.5 26.8 35.6 26.8 28.6 21.6 19.3 11.4
Non-Current Liabilities
Long-Term Debt 47.7 13.2 0 0 0 0.5 1.6 3.9
Deferred Tax Liabilities 0.4 0 0 0 0 0 0 (1.6)
Other Non-Current Liabilities 5.0 4.2 3.4 2.8 4.9 6.5 4.8 3.6
Total Non-Current Liabilities 65.8 32.0 19.1 16.9 16.2 10.0 10.1 10.4
Total Liabilities 116.3 58.8 54.7 43.7 44.8 31.6 29.4 21.8
Stockholders' Equity
Common Stock 4.8 4.2 4.0 3.5 3.3 2.5 1.9 1.9
Retained Earnings (519.3) (440.3) (377.8) (298.8) (211.4) (137.7) (98.3) (64.5)
Accumulated Other Comprehensive Income 89.2 61.0 54.0 24.0 12.5 8.3 (0.6) (0.0)
Total Stockholders' Equity 47.1 96.5 151.4 200.1 275.4 100.5 22.3 54.8
Total Liabilities & Equity 163.5 155.3 206.2 243.8 320.2 132.1 51.7 76.6
Debt Metrics
Total Debt 63.0 30.0 18.6 16.7 13.1 7.2 8.5 9.2
Net Debt (7.3) (50.2) (104.7) (144.6) (179.9) (67.4) (9.6) (44.7)
Metric 2025 2024 2023 2022 2021 2020 2019
Operating Activities
Net Income (79.0) (61.3) (78.5) (87.6) (73.5) (41.2) (33.6)
Depreciation & Amortization 9.5 8.6 8.3 5.6 3.6 2.4 1.9
Stock-Based Compensation 0 16.5 15.2 13.6 8.5 1.4 0.7
Change in Working Capital 10.7 (2.6) 0.9 (1.3) 6.1 3.8 (1.6)
Other Non-Cash Items 20.8 (3.3) 6.6 0.9 (1.1) 2.7 1.4
Operating Cash Flow (38.0) (42.8) (48.6) (70.1) (57.9) (31.7) (31.7)
Investing Activities
Capital Expenditure (0.6) (8.2) (9.2) (10.4) (6.7) (3.2) (3.0)
Acquisitions 0 0 0 0 4.0 0 0
Purchases of Investments (1.9) 0 0 (26.2) (72.1) (21.1) 0
Sales/Maturities of Investments 0 0 17.5 78.5 21.9 0 0
Other Investing Activities 0 (7.9) (7.7) (6.3) (4.0) (2.8) (1.7)
Investing Cash Flow (10.5) (8.2) 8.3 42.0 (56.9) (24.3) (3.0)
Financing Activities
Net Debt Issuance 32.7 11.2 (3.0) (2.3) (4.1) (1.7) (2.8)
Stock Repurchased 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities 0 0 0.2 0.7 10.5 1.1 1.8
Financing Cash Flow 34.1 11.6 (2.8) (1.6) 237.8 107.0 (1.0)
Cash Position
Net Change in Cash (9.9) (43.0) (38.1) (31.7) 118.3 56.6 (35.8)
Cash at Beginning 80.2 123.3 161.3 193.0 74.6 18.1 53.9
Cash at End 70.3 80.2 123.3 161.3 193.0 74.6 18.1
Free Cash Flow (38.6) (51.0) (57.8) (80.5) (64.6) (34.9) (34.7)
Key Metrics 2025 2024 2023 2022 2021 2020 2019
Income Statement
Revenue 77.3 65.2 62.4 47.6 40.5 28.4 25.4
Gross Profit 47.8 43.9 42.9 31.3 25.2 17.7 17.8
Operating Income (70.9) (66.6) (74.8) (87.8) (71.5) (37.4) (32.3)
Net Income (79.0) (62.5) (79.0) (87.4) (73.7) (39.3) (33.8)
EPS (Diluted) -1.17 -0.95 -1.22 -1.36 -1.33 -0.82 -0.53
Balance Sheet
Cash & Equivalents 70.3 80.2 123.3 161.3 193.0 74.6 18.1 53.9
Total Assets 163.5 155.3 206.2 243.8 320.2 132.1 51.7 76.6
Total Debt 63.0 30.0 18.6 16.7 13.1 7.2 8.5 9.2
Stockholders' Equity 47.1 96.5 151.4 200.1 275.4 100.5 22.3 54.8
Cash Flow
Operating Cash Flow (38.0) (42.8) (48.6) (70.1) (57.9) (31.7) (31.7)
Capital Expenditure (0.6) (8.2) (9.2) (10.4) (6.7) (3.2) (3.0)
Free Cash Flow (38.6) (51.0) (57.8) (80.5) (64.6) (34.9) (34.7)